Education
About Us
Working with TipRanks
Follow Us
Linda M Rubinstein Insider Profile
4 Followers
Linda M Rubinstein, Director at Biocept, holds ― shares in Biocept (Ticker: BIOCQ), holds 19.32K shares in Adverum Biotechnologies (Ticker: ADVM). Most recently, Linda M Rubinstein ― shares of Biocept on ― for an estimated value of ―.
Linda M Rubinstein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Linda M Rubinstein holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Jun 09, 2023 - Jun 09, 2024
Return:-52.80%
The most profitable trade made by Linda M Rubinstein
Linda M Rubinstein's Trading History
Biocept
―
Director
―
―
Adverum Biotechnologies
Feb 27, 2025
CFO
Uninformative Buy
―
$88.51K
List of latest transactions for each holding click on a transaction to see Linda M Rubinstein's performance on stock
You May Also Like
Linda M Rubinstein insider profile FAQ
What is the percentage of profitable transactions made by Linda M Rubinstein?
The percentage of profitable transactions made by Linda M Rubinstein is ―.
What is the average return per transaction made by Linda M Rubinstein?
The average return per transaction made by Linda M Rubinstein is ―.
What stocks does Linda M Rubinstein hold?
Linda M Rubinstein holds: BIOCQ, ADVM stocks.
What was Linda M Rubinstein’s latest transaction?
Linda M Rubinstein latest transaction was an Uninformative Buy of ―.
What was Linda M Rubinstein's most profitable transaction?
Linda M Rubinstein’s most profitable transaction was an Informative Buy of ADVM stock on June 9, 2023. The return on the trade was -52.80%.
What is Linda M Rubinstein's role in Biocept?
Linda M Rubinstein's role in Biocept is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.